Leucomalacie périventriculaire du prématuré

Medecine Therapeutique Pediatrie

Volumn 1, Issue 5, 1998, Pages 409-418

  Baud, Olivier ^a   Zupan, Véronique ^a   Lacaze Masmonteil, Thierry ^a  

^a Serv Ped Reanimat Neonatale   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2842590208     PISSN: 12865494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Kuban K C.K., Leviton A. 1994. Cerebral palsy. N Engl J Med 330 : 188-195.
2. Rumeau-Rouquette C , et al 1994. Prévalence des handicaps : évolution dans trois générations d'enfants - 1972, 1976, 1981. Paris: INSERM, 177p.
3. Levene M.I., de Vries L.S 1995. Cerebral ischemic lesions In: Fetal and neonatal neurology and neurosurgery. Londres : Churchill Livingston, 367-379.
4. Zupan V., Gonzalez P. 1995. Leucomalacie périventriculaire : un risque accru avec la rupture prématurée des membranes et l'infection. In : Dehan M., Frydman R., eds. Les cahiers de l'AP-HP, JPOP 1995. Paris : AP-HP/Doin: 97-101.
5. Perlman J.M., Risser R., Broyles R.S. 1996 Bilateral cystic periventricular leukomalacia in the premature infant : associated risk factors. Pediatrics 97 . 822-827.
6. Murphy D.J., et al. 1995. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies, Lancet 346 : 1449-1454.
7. Grether J.K., Nelson K.B., Emery III E.S., Cummins S.K. 1996. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J Pediatr 128 : 407-414.
8. Evrard P., Gressens P, Volpe J.J. 1992. New concepts to understand the neurological consequences of subcortical lesions in the premature brain. Biol Neonate 61 : 1-3.
9. Adinolfi M. 1993. Infectious diseases in pregnancy, cytokines and neurological impairment : an hypothesis. Dev Med Child Neurol 35 : 549-553.
10. Leviton A. 1993. Preterm birth and cerebral palsy : is tumor necrosis factor the missing link ? Dev Med Child Neurol 35 - 553-558
11. Yoon B.H., et al. 1995. Amniotic fluid interleukin-6 : a sensitive test for antenatal diagnosis of acute inflammatory lesions of preterm placenta and prediction of perinatal morbidity. Am J Obstet Gynecol 172 : 960-970.
12. Yoon B.H., et al. 1996. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 174 : 1433-1440.
13. Baud O., et al. 1998. Amniotic fluid concentrations of cytokines in chorioamnionitis before 32 weeks' gestation : clinical and anatomical correlations. Br J Obstet Gynaecol 105 (sous presse).
14. Gozes I., Brenneman D.E. 1989. VIP: molecular biology and neurobiological function. Mol Neurobiol 3 : 201-236.
15. Marret S., et al 1995. Effects of ibotenate on brain development : an excitotoxic mouse model of microgyria and post-hypoxic-like lesions. J Neuropathol Exp Neurol 54 . 358-370.
16. Leviton A., Gilles F H. 1984. Acquired perinatal leucoencephalopathy. Ann Neurol 16 : 1-8.
17. Volpe J.J. 1995. Human brain development In : Volpe J.J., ed. Neurology of the newborn. Philadelphie : WB Saunders Company, 3-43.
18. Oka A., et al. 1993. Vulnerability of oligodendroglia to glutamate : pharmacology, mechanism and prevention. J Neurosci 13 : 1441-1453.
19. Guan J , et al. 1993. The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adults rats J Cereb Blood Flow Metab 13 : 609-646.
20. Hill J.M., et al. 1994. Distribution ofVIP mRNA and two distinct VIP binding sites in the developing rat brain : relation to ontogenic events. J Comp Neurol 342 : 186-205.
21. Gressens P., et al. 1994. Blockade of vasoactive intestinal peptide function in early mouse embryo induces a severe microcephaly. J Clin Invest 94 : 2020-2027.
22. Gressens P., et al. 1996 Le peptide vasoactif intestinal : un nouveau facteur neurotrophique. Arch Ped 5 : 654-660.
23. Reuss M.L., Paneth N., Susser M. 1994. Does the loss of placental hormones contribute to neurodevelopmental disabilities in preterm infants ? Dev Med Child Neurol 36 : 743-747.
24. Paneth N., Rudelli R., Kazam E., Monte W. 1994. Brain damage in the preterm infant. Londres : Mac Keith Press, 212 p.
25. Crawford C.L., Hobbs M.J. 1994. Anatomy of diplegia : an hypothesis. Dev Med Child Neurol 36 : 513-517.
26. Goto M., et al. 1994. MRI changes and deficits of higher brain functions in preterm diplegia. Act Paediatr 83 : 506-511.
27. Dammann O., Leviton A. 1997 Duration of transient hyperechoic images of white matter in very low birthweight infants : a proposed classification. Dev Med Child Neurol 39 : 2-5.
28. Debillon T., et al. 1993. Leucomalacie périventriculaire d'apparition tardive chez un prématuré. Arch Fr Pediatr 50 : 671-674.
29. Baud O., et al. 1998. The early diagnosis of periventricular leukomalacia in premature infants with positive rolandic sharp waves on serial electro-encephalography. J Pediatr 132 : 813-817.
30. Schouman-Claeys E., et al. 1993, Periventricular leucomalacia : correlation between MR imaging and autopsy findings during the first 2 months of life. Radiology 189 : 59-64.
31. Rogers B., et al. 1993. Cystic periventricular leukomalacia and type of cerebral palsy in preterm infants. J Pediatr 125 : S1-S8.
32. Relly S., Skuse D., Poblete X. 1996. Prevalence of feeding problems and oral motor dysfunction in children with cerebral palsy, J Pediatr 129 : 877-882.
33. Eken P., et al. 1994. Relation between neonatal cranial ultrasound abnormalities and cerebral visual impairement in infancy. Dev Med Child Neurol 36 : 3-15.
34. Prechtl H.F.R., Einspieler C, Cioni G., Bos A.F., Ferrari F., Sontheimer D. 1997. An early marker for neurological deficits after perinatal brain lesions. Lancet 349 : 1361-1363.
35. Hernandorena X., Contraires B., Carré M., Sainz M., Bouchet E., Grenier A. 1995. Surveillance neurologique des nouveau-nés à risque d'infirmité motrice cérébrale. Arch Pediatr 2 : 941-947.
36. Marret S., Zupan V., Gressens P., Lagercrantz H., Evrard P. 1998. Les leucomalacies périventriculaires. Arch Pediatr 5 : 525-545.
37. Marret S., et al. 1995. Prevention by magnesium of excitotoxic neuronal death in developing brain : an animal model for the clinical intervention studies Dev Med Child Neurol 37 : 473-484.
38. Nelson K.B., Grether J.K. 1995. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants ? Pediatrics 95 : 263-269
39. Leviton A., et al. 1997. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage Pediatrics 99 (4) : e2.
40. Schendel D.E , et al. 1996. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 276 : 1805-1810.
41. Baud O., et al. 1998. Neonatal brain lesions due to intrauterine infection are related to mode of delivery. Br J Obst Gynecol 105 : 121-124.